Iberin for Health & Longevity

Evidence Review created on 08/28/2026 using AI4L / Opus 5

Also known as: 3-methylsulfinylpropyl isothiocyanate, 3-(methylsulfinyl)propyl isothiocyanate, 1-isothiocyanato-3-(methylsulfinyl)propane

Motivation

Iberin is a sulfur-containing compound that forms when cabbage, broccoli, Brussels sprouts, or horseradish are chopped or chewed. It belongs to the same chemical family as sulforaphane, the better-known broccoli compound, and differs from it only by a shorter carbon chain. Like its relatives, it appears to switch on the body’s own protective and waste-clearing machinery rather than acting as an antioxidant directly.

Its storage form sits in cabbage-family plants right beside the one that yields sulforaphane, so anyone eating these vegetables already takes in iberin, and measurable amounts of its breakdown products turn up in blood and urine afterwards. Laboratory work has also singled it out as an unusually strong blocker of certain inflammation switches and of the chemical signaling bacteria use to coordinate themselves. Isolated iberin is sold only as a laboratory chemical.

This review examines what is known about iberin as a distinct compound rather than as one ingredient of a vegetable: how it behaves in the body, what the laboratory and animal findings do and do not show, what the safety picture looks like, and where the evidence stops.

Benefits - Risks - Protocol - Conclusion

Grokipedia

No Grokipedia article exists for iberin. A direct search of grokipedia.com returned only two spider-genus entries with similar names and one plant entry that mentions the compound in passing, with no dedicated page.

Examine

No Examine article exists for iberin. The site’s search returns only pages on methylliberine, an unrelated purine alkaloid whose name happens to contain the same letter sequence.

ConsumerLab

No ConsumerLab article exists for iberin. The site returns no results of any type for the term, which is consistent with there being no finished consumer product containing isolated iberin for ConsumerLab to test.

Systematic Reviews

No systematic reviews or meta-analyses for iberin were found on PubMed as of 28 August 2026.

Neither side of iberin’s central trade-off is represented: there is no systematic review or meta-analysis of its claimed chemoprotective effect, and none of its principal risk, the reactive thiol chemistry it shares with all isothiocyanates. The literature is too small for either to have been synthesized.

Mechanism of Action

Iberin does not exist in intact plants. Cabbage-family tissue stores it as glucoiberin, a glucosinolate (the inert, sulfur-rich storage form held in a separate cell compartment). Tissue damage releases myrosinase (the plant enzyme that cleaves glucosinolates), converting glucoiberin into iberin; gut bacteria do the same after cooking destroys that enzyme.

The isothiocyanate group is strongly electrophilic, reacting with exposed cysteine residues rather than binding a receptor. That single chemistry produces the whole profile. Modifying Keap1 (the sensor protein holding Nrf2 inactive) frees Nrf2 (the master switch for antioxidant and detoxification genes) to raise heme oxygenase-1 (a stress-protective enzyme) and glutathione-synthesis enzymes (Ernst et al., 2013). The same reactivity modifies Toll-like receptors (surface sensors that detect microbes and trigger inflammation), blocking the pairing step they need to signal (Shibata et al., 2014).

It is unselective and short-lived. Plasma total isothiocyanate falls with a half-life near 1.8 hours (Ye et al., 2002); urinary iberin conjugates clear with a half-life near 2.5 hours (Oliviero et al., 2014). Metabolism runs through the mercapturic acid pathway (the body’s route for tagging reactive chemicals with glutathione and clearing them in urine), via glutathione S-transferase enzymes. The rodent response concentrates in bladder, duodenum and forestomach (Munday & Munday, 2004). Iberin left cytochrome P450 drug-metabolizing enzymes untouched (Elbarbry et al., 2024).

A competing reading attributes the anticancer effects to redox stress, not Nrf2: iberin raises reactive oxygen species (damaging oxygen molecules) and depolymerizes tubulin; quenching them abolishes the effect (Pocasap et al., 2019; Gong et al., 2021).

Historical Context & Evolution

Iberin owes its name to Iberis amara, bitter candytuft, from which its storage form glucoiberin was first characterized; the plant remains the reference source for the pure glucosinolate standard (Jaki et al., 2002). Iberis amara itself entered European herbal practice for digestive complaints, not for the compound now under discussion, and the isothiocyanate first interested agricultural chemists studying why insects select or reject Brassica crops.

Its move into health research was indirect. When glucosinolate breakdown products from Brussels sprouts were screened together for detoxification-enzyme induction, iberin was tested at the dose reflecting its natural abundance and produced only a modest, largely non-significant response; indole-3-carbinol and crambene accounted for most of the effect (Staack et al., 1998). Six years later, dosed on a molar rather than dietary basis, iberin raised quinone reductase (an enzyme that neutralizes reactive quinones) and glutathione S-transferase in rat tissue about as well as sulforaphane (Munday & Munday, 2004). Both findings stand; the discrepancy is one of dose and reference basis, not method quality, and the earlier negative result is often dropped from later summaries.

Two later results moved iberin out of sulforaphane’s shadow: its isolation from horseradish as a bacterial signaling inhibitor (Jakobsen et al., 2012) and its identification as the most potent inflammation-blocking compound in a broad vegetable screen (Shibata et al., 2014). Opinion has not settled: whether iberin is a meaningful contributor to cruciferous benefit or a minor congener of sulforaphane remains open, and no human outcome study has been run either way.

Expected Benefits

High 🟩 🟩 🟩

No benefit reaches High: not one human clinical endpoint and not one validated clinical surrogate - blood pressure, HbA1c (a three-month average of blood sugar), a lipid fraction, or a named rating scale - has been measured under iberin in any trial, let alone in more than one.

Medium 🟩 🟩

No benefit reaches Medium either: there is no single human trial and no observational cohort measuring any clinical outcome attributable to iberin itself, as distinct from whole cruciferous vegetable intake.

Low 🟩

Reliable Systemic Exposure from Ordinary Cruciferous Meals

Iberin released from glucoiberin reaches the circulation and is excreted as mercapturic acid pathway conjugates, so dietary intake produces genuine systemic exposure rather than gut-limited contact. Controlled human feeding studies measured this directly (Oliviero et al., 2014). The data are human but indirect, since exposure is not a health outcome.

Magnitude: In a 15-participant crossover feeding study, 19-29% of the ingested dose was recovered in urine as iberin conjugates, with an excretion half-life near 2.5 hours; plasma total isothiocyanate peaked at 0.94-2.27 µmol/L one hour after a 200 µmol broccoli sprout dose.

Speculative 🟨

Activation of the Nrf2 Antioxidant and Detoxification Program ⚠️ Conflicted

Iberin moves Nrf2 into the nucleus and raises heme oxygenase-1 like sulforaphane (Ernst et al., 2013). Rat dosing raised detoxifying enzymes; a dietary-abundance comparison did not. Net: consistent in cells, inconsistent in rodents.

Suppression of Inflammatory Signaling

Iberin was the most potent inflammation-blocking compound in a broad vegetable screen, blocking Toll-like receptor pairing (Shibata et al., 2014). It also cut interleukin-6 output in oral cells. All data are in vitro.

Growth Arrest and Apoptosis in Tumor Cell Lines

Iberin halts division and triggers cell death in ovarian, glioblastoma, colon and liver cell lines, partly through reactive oxygen species and histone-modifying activity (Gong et al., 2021). No animal survival or human data exist.

Quorum-Sensing Inhibition and Antibacterial Activity

Iberin blocks the signaling Pseudomonas aeruginosa uses to build biofilms and virulence factors (Jakobsen et al., 2012). Evidence is bacterial culture and one skin-explant model only, with no infection outcome in any organism.

Protection Against Kidney Ischemia-Reperfusion Injury

Pre-treatment with iberin lowered inflammatory and cell-death markers after renal artery clamping in rats (Yahiya et al., 2023). Basis is one small animal study using surrogate markers, not kidney function.

Benefit-Modifying Factors

Gut microbiome composition: Some microbial communities divert glucoiberin to iberin-nitrile, a biologically inert product, instead of iberin. Nitrile output varies widely between individuals and tracks with Clostridiaceae abundance, so identical vegetable intake yields unequal exposure (Bouranis et al., 2021).
Glutathione S-transferase gene variants: The GSTM1 and GSTT1 deletions and the GSTP1 Ile105Val variant alter the enzymes that conjugate iberin. Counter to expectation, GSTM1-null individuals excreted more isothiocyanate metabolites, not less, implying alternative clearance routes (Steck et al., 2007).
Baseline oxidative and inflammatory status: Nrf2 activation adds most where the antioxidant program is under-expressed. Someone with an already low high-sensitivity C-reactive protein (a general marker of body-wide inflammation) has less headroom, so change is likelier from a worse starting position.
Food matrix and myrosinase survival: Retaining as little as 2% of the plant enzyme still produced intermediate iberin recovery, while complete inactivation cut it to about a fifth; protein, fiber and lipid gels shifted recovery further (Oliviero et al., 2014).
Sex: No human study has reported iberin outcomes by sex. Broccoli sprout feeding produced sex-dependent cardiometabolic and lifespan effects in rats, so a sex difference is plausible but wholly unestablished in people.
Pre-existing health conditions: Impaired kidney function slows the renal tubular secretion that clears isothiocyanate conjugates, and inflammatory bowel disease alters the microbial conversion step. Both would shift exposure, though neither has been measured with iberin.
Age: Nrf2 responsiveness declines with age, which could blunt the main proposed benefit in exactly the older adults most interested in it; conversely, baseline inflammation is higher, leaving more room to move. Neither effect has been tested.

Potential Risks & Side Effects

High 🟥 🟥 🟥

No risk reaches High: no adverse event has ever been recorded under iberin in a human being, because iberin has never been administered to one as an isolated compound, so no clinical endpoint or validated surrogate exists in even a single trial.

Medium 🟥 🟥

No risk reaches Medium either: there is no single human trial and no observational dataset in which iberin exposure was the variable, so no adverse outcome can be attributed to it from consistent observational data.

Low 🟥

Gastrointestinal and Oropharyngeal Irritation

Isothiocyanates are the pungent principles of horseradish, mustard and wasabi, and concentrated intake produces burning and gastric discomfort. A human phase I study of broccoli sprout isothiocyanates recorded no abnormal events across 21 doses (Shapiro et al., 2006), but that preparation was iberin-poor. Evidence for iberin is uncontrolled and inferential.

Magnitude: Not quantified in available studies. No controlled trial has administered isolated iberin to humans at any dose, so no incidence figure for irritation exists; the only human tolerability data come from mixed broccoli sprout extracts in which iberin was a minor constituent.

Thyroid Function Disruption ⚠️ Conflicted

Glucosinolate breakdown yields thiocyanate, which competes with iodide for thyroid uptake. Against this, a 12-week randomized trial of a glucoraphanin-rich beverage left thyroid-stimulating hormone (the pituitary signal driving thyroid output), free thyroxine and thyroglobulin unchanged (Chartoumpekis et al., 2019). Net: a real mechanism, unconfirmed at dietary exposures.

Magnitude: In 45 women given the beverage for 84 days, thyroid-stimulating hormone, free thyroxine, thyroglobulin and thyroid autoantibody status all showed no treatment effect; the literature reports no outcome figure for iberin itself, which was not measured.

Speculative 🟨

Cytotoxicity and Oxidative Stress in Non-Malignant Cells

Iberin’s cytotoxicity is not selective for tumors: it inhibited human leukemia cells at 1-4 µM, the same range that killed the parasites under test (Steverding et al., 2014). Basis is cell culture only.

DNA Damage Response and Necrosis Above the Cytotoxic Threshold

Above its half-maximal inhibitory concentration in colon cells, iberin shifted from protective enzyme induction to DNA strand-break signaling and necrosis (Jakubikova et al., 2006). Cell-culture data only; no animal or human threshold is mapped.

Altered Handling of Co-Administered Medications

Iberin induces glutathione S-transferase, quinone reductase and thioredoxin reductase (which keeps cell proteins in working shape), so it could speed clearance of drugs using those routes (Wang et al., 2005). No interaction study exists.

Mucosal and Airway Irritation from Concentrated Preparations

Research-grade isothiocyanates are supplied as neat liquids and are corrosive and tear-inducing; isolated reports of skin inflammation and airway irritation exist for related compounds. No human exposure data for iberin have been published.

Risk-Modifying Factors

Glutathione S-transferase gene variants: GSTM1 and GSTT1 deletions and the GSTP1 Ile105Val variant change how quickly reactive isothiocyanates are conjugated and cleared. Their net direction is unsettled, as GSTM1-null individuals unexpectedly excreted more metabolites (Steck et al., 2007).
Baseline thyroid and iodine status: Marginal iodine intake or existing autoimmune thyroid disease is the setting in which competitive iodide-uptake inhibition would matter. The 12-week trial that found no thyroid signal enrolled participants without established thyroid disease.
Sex: No sex-stratified adverse-event data exist for iberin or for any short-chain isothiocyanate. Because autoimmune thyroid disease is several times more common in women, any thyroid-mediated risk would fall disproportionately on them.
Pre-existing health conditions: Reduced kidney function slows clearance of isothiocyanate conjugates, which depend on active renal tubular secretion. Peptic ulcer disease and gastro-esophageal reflux plausibly worsen with pungent isothiocyanate loads, though this has not been formally studied.
Age: Glutathione synthesis capacity and renal clearance both decline with age, so older adults would accumulate reactive metabolite for longer. No pharmacokinetic study has enrolled participants over 65 for iberin specifically.

Key Interactions & Contraindications

Thiol-containing supplements (N-acetylcysteine, glutathione, alpha-lipoic acid): Caution - these directly quench isothiocyanates. N-acetylcysteine abolished iberin’s cellular effects entirely (Gong et al., 2021). Mitigation: separate intake by at least four hours, or omit on cruciferous-loading days.
Selenium: Additive, potentially desirable. Selenium markedly amplified isothiocyanate-driven thioredoxin reductase induction in human cells (Wang et al., 2005). Keep total selenium below 400 µg/day to avoid selenosis (selenium overload, causing hair and nail loss).
Other isothiocyanates (sulforaphane, erucin, alyssin, iberverin): Additive at the same target. Combinations lowered the antibacterial threshold four- to eightfold (Nowicki et al., 2020). Consequence: stacked cruciferous extracts raise total reactive load and irritation potential.
Vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon): Caution, indirect. The cruciferous vegetables that supply iberin are also vitamin K-rich, which opposes anticoagulation. Mitigation: hold cruciferous intake constant week to week and monitor the international normalized ratio.
Thyroid hormone replacement (levothyroxine, liothyronine): Monitor. Any competitive iodide-uptake effect would shift dose requirements. Mitigation: separate dosing by four hours and check thyroid-stimulating hormone after any large sustained increase in cruciferous intake.
Acetaminophen and other glutathione-depleting agents: Caution, theoretical. Both consume glutathione, and heavy simultaneous loads could deplete reserves. Consequence: reduced capacity to detoxify reactive intermediates. Mitigation: avoid high-dose cruciferous extracts alongside repeated maximal acetaminophen dosing.
Over-the-counter proton pump inhibitors and antacids (omeprazole, calcium carbonate): Minor. Raised gastric pH slows glucosinolate breakdown by residual plant enzyme, lowering iberin yield. Mitigation: rely on raw, chewed cruciferous sources rather than cooked ones.
Other interventions - fasting and ketogenic protocols: Minor, indirect. Both independently raise Nrf2 tone, so the marginal contribution of iberin is likely smaller in someone already running such a protocol. Consequence: reduced incremental effect rather than added harm. No study has tested the combination.

Populations who should avoid Iberin:

Anyone considering isolated iberin from a chemical supplier, since every commercial source is labelled not for human consumption and no purity, dose or toxicology standard exists.
Pregnant and breastfeeding women, for whom no reproductive toxicology of any kind has been performed on this compound.
People with untreated or poorly controlled hypothyroidism (thyroid-stimulating hormone above 10 mIU/L) or documented iodine intake below 100 µg/day, in whom competitive iodide-uptake inhibition would be least tolerable.
People with active peptic ulceration or erosive esophagitis (Los Angeles grade C or D), for whom concentrated pungent isothiocyanates are a direct mucosal irritant.
People with advanced chronic kidney disease (estimated glomerular filtration rate below 30 mL/min/1.73 m², a measure of filtering capacity), because conjugate clearance depends on active renal tubular secretion.

Risk Mitigation Strategies

Food sources rather than isolated chemical: Eating broccoli, cabbage, Brussels sprouts or horseradish caps exposure at a few micromoles per serving, avoiding the uncharacterized dosing and corrosive handling risks of research-grade material entirely.
Gradual introduction of cruciferous loading: Building from one serving daily to three or four over two to three weeks limits the gastrointestinal and oropharyngeal irritation that is the most likely adverse effect at food-level intakes.
Thyroid status established before sustained high-cruciferous protocols: Baseline thyroid-stimulating hormone, free thyroxine and thyroid peroxidase antibodies identify the marginal-iodine or autoimmune cases in which the unresolved thyroid concern would matter.
Iodine intake of 150 µg/day: Adequate iodine offsets any competitive uptake inhibition from thiocyanate generated alongside iberin, which is the specific mechanism behind the thyroid concern.
Steady cruciferous intake around narrow-margin medications: Constant week-to-week intake, with the international normalized ratio or thyroid-stimulating hormone rechecked after any sustained change, limits the altered drug handling that induction of the body’s detoxification enzymes can produce.
No stacking of concentrated isothiocyanate extracts: Combining broccoli seed, mustard seed and horseradish concentrates multiplies total reactive thiol load, which drives both the irritation risk and the non-selective cytotoxicity seen in cell work.

Therapeutic Protocol

No isolated-iberin protocol exists: No practitioner administers iberin as such. Every practical approach delivers it as one component of a cruciferous glucosinolate load, and no dose-finding study has ever been performed on the isolated compound.
The Johns Hopkins broccoli sprout approach: Popularized by Paul Talalay and Jed Fahey, this uses standardized sprout extracts dosed by glucosinolate or isothiocyanate content; the phase I protocol gave 25-100 µmol at eight-hour intervals for seven days.
The whole-food alternative: Raw or lightly steamed cruciferous vegetables, three to five servings daily, with horseradish or mustard as concentrated additions. Neither approach is established as superior; the extract route trades matrix effects for dose precision.
Time of day: Distribution matters more than clock time. Because plasma isothiocyanate peaks within one hour, splitting intake across meals sustains exposure better than a single large serving.
Half-life: Plasma total isothiocyanate falls with a half-life near 1.8 hours and urinary iberin conjugates with a half-life near 2.5 hours, so no accumulation occurs between doses (Ye et al., 2002).
Split versus single dosing: Split dosing is the only regimen with human pharmacokinetic support; the phase I study used three daily administrations precisely because a single dose leaves most of the day without measurable exposure.
Genetic polymorphisms: GSTM1, GSTT1 and GSTP1 status alters conjugation and clearance but does not currently justify dose adjustment, since GSTM1-null individuals excreted more rather than less metabolite (Steck et al., 2007).
Sex-based differences: None established. No human study has reported iberin pharmacokinetics or response separately by sex, and the only sex-dependent findings come from rat broccoli sprout feeding.
Age-related considerations: Reduced renal clearance and lower glutathione synthesis in later life argue for the lower end of any cruciferous loading range, though no pharmacokinetic study has enrolled adults over 65.
Baseline biomarkers: Baseline high-sensitivity C-reactive protein and gamma-glutamyl transferase (an enzyme reflecting glutathione turnover) define the headroom available; someone already at the optimal end has less to gain from increased intake.
Pre-existing conditions: Autoimmune thyroid disease, advanced kidney disease and erosive upper gastrointestinal disease each argue against high-dose cruciferous protocols, on mechanistic grounds rather than on recorded events.

Discontinuation & Cycling

Intended duration: Dietary cruciferous intake is a lifelong pattern rather than a course. No case has been made for time-limited isolated iberin, since no defined starting protocol exists to stop.
Withdrawal effects: None documented. Given a plasma half-life under two hours and no receptor occupancy or downregulation, no rebound or dependence phenomenon is mechanistically plausible or has been reported.
Tapering: Not applicable to a food-derived compound cleared within hours. Abrupt cessation simply returns Nrf2-dependent enzyme expression to baseline over the normal protein turnover period of a few days.
Cycling: Not established as necessary. No tolerance or diminishing response has been shown for isothiocyanates, although induced enzyme levels plateau, so continuous rather than pulsed intake has no demonstrated disadvantage.

Sourcing and Quality

No consumer-grade iberin product exists: Iberin is sold only as a research chemical by suppliers such as LKT Laboratories, Cayman Chemical and Toronto Research Chemicals, at milligram scale, labelled not for human consumption and without any dietary-supplement quality framework.
Practical sourcing is the plant: Glucoiberin is concentrated in Brussels sprouts, cabbage, broccoli and horseradish. Horseradish gave the strongest activity of every food screened and was the extract iberin was isolated from (Jakobsen et al., 2012).
What to look for in cruciferous extracts: A stated glucosinolate content, declared active myrosinase or an enteric dual-layer delivery format, and a total isothiocyanate assay rather than a raw plant-weight claim, which says nothing about deliverable compound.
Third-party testing: For any cruciferous supplement, NSF Certified for Sport, USP Verified or ConsumerLab approval confirms identity and contaminant limits. No certification programme currently covers iberin content specifically, since no reference product exists.
Formulation stability: Isothiocyanates degrade in aqueous solution and with heat, so powders and enteric tablets outperform liquids. Products relying on glucosinolate plus separated enzyme mimic the plant’s own two-compartment arrangement.
Brands in the adjacent category: Avmacol and Prostaphane are the extract formats used in registered clinical research; both are standardized to glucoraphanin rather than glucoiberin, so their iberin contribution is real but undeclared.

Practical Considerations

Time to effect: Enzyme induction is measurable within hours and plateaus within days, but no clinical outcome has ever been observed, so no meaningful time-to-benefit can be stated for iberin at all.
Common pitfalls: Boiling destroys myrosinase and cuts isothiocyanate yield to roughly a fifth; assuming a glucosinolate label equals delivered compound; and treating cell-culture concentrations as though they were achievable dietary exposures.
Regulatory status: Iberin is not an approved drug anywhere and is not a recognized dietary ingredient under the U.S. Food and Drug Administration’s supplement framework. In the European Union an isolated iberin preparation would require novel food authorization.
Cost and accessibility: The food route is inexpensive and universally available. Isolated iberin is priced as a research reagent, orders of magnitude above the food route per gram, and given the absence of human data is not a rational purchase.
Analytical verification is impractical: Confirming personal exposure requires liquid chromatography-tandem mass spectrometry of urinary conjugates, a research assay not offered by consumer laboratories (Al Janobi et al., 2006).

Interaction with Foundational Habits

Sleep: No direct interaction is established. Iberin has no known central nervous system activity, no stimulant or sedative property, and a plasma half-life under two hours, so evening intake is unlikely to disturb sleep architecture. The indirect route, through lowered inflammatory tone, is plausible but untested.
Nutrition: Direct and decisive. Iberin exists only as a product of food preparation, so chewing thoroughly, eating cruciferous vegetables raw or lightly steamed, and adding a myrosinase-rich food such as mustard powder to cooked crucifers all raise yield. Fat, protein and fiber matrices measurably shift absorption (Oliviero et al., 2018).
Exercise: Potentially blunting, on the same theoretical grounds argued for high-dose antioxidants. Because Nrf2 activation is part of how training adaptation is signalled, saturating that pathway around workouts could theoretically dampen it. No study has tested iberin with exercise; the concern is extrapolated from vitamin C and E trials.
Stress management: Indirect only. Iberin has no measured effect on cortisol or on the hypothalamic-pituitary-adrenal axis (the hormonal stress-response loop). Any link runs through inflammation, which chronic psychological stress raises and which iberin lowers in cell models, leaving the practical relevance speculative.

Monitoring Protocol & Defining Success

Because no clinical endpoint has been established for iberin, monitoring here serves safety and exposure verification rather than efficacy. Before starting a sustained high-cruciferous protocol, a baseline panel covering thyroid function and autoimmunity, systemic inflammation, liver enzymes and kidney filtration establishes the reference points against which any change is judged, and identifies the marginal-iodine or autoimmune-thyroid situations in which caution is warranted. Ongoing testing should repeat the thyroid panel at 12 weeks, then at 6 and 12 months, with the inflammatory, liver and kidney markers repeated every 6 to 12 months thereafter. Success is defined negatively for the safety markers - thyroid and liver values holding within their baseline range - and positively only for the inflammatory marker, where a downward drift would be consistent with, though not proof of, an effect.

Biomarker	Optimal Functional Range	Why Measure It?	Context/Notes
TSH	0.5-2.0 mIU/L	Detects the thyroid suppression that is the main theoretical hazard	TSH stands for thyroid-stimulating hormone, the pituitary signal driving thyroid output; conventional range is wider at 0.45-4.50 mIU/L. Draw fasting in the morning, when levels peak
Free T4	1.0-1.5 ng/dL	Confirms actual hormone output when TSH shifts	T4 is thyroxine, the main circulating thyroid hormone; pair with TSH in the same draw. Conventional range extends to 1.8 ng/dL
TPO antibodies	Negative, below 9 IU/mL	Identifies pre-existing autoimmune thyroid disease before loading begins	TPO is thyroid peroxidase, the enzyme that builds thyroid hormone; antibodies against it mark autoimmunity. Test once at baseline unless the thyroid panel shifts
hs-CRP	Below 0.5 mg/L	Tracks the systemic inflammation the intervention is proposed to lower	hs-CRP is high-sensitivity C-reactive protein, a general inflammation marker; conventional low-risk cut-off is the far looser 3.0 mg/L. Invalid within two weeks of infection or injury
GGT	Below 20 U/L	Proxy for glutathione turnover, which iberin consumes and induces	GGT is gamma-glutamyl transferase, an enzyme central to glutathione recycling; conventional upper limits run to 55 U/L. Alcohol raises it independently
ALT	Below 20 U/L in men, below 17 U/L in women	Detects liver-cell stress from any concentrated extract	ALT is alanine aminotransferase, a liver-cell enzyme; conventional limits reach 40 U/L. Pair with GGT; strenuous exercise within 48 hours inflates it
eGFR	Above 90 mL/min/1.73 m²	Clearance of iberin conjugates depends on renal tubular secretion	eGFR is estimated glomerular filtration rate, a calculated measure of kidney filtering capacity; use the creatinine-cystatin C equation where available. Fasting not required
Urinary isothiocyanate conjugates	No established target exists; track the change from the individual’s own pre-intervention baseline	Verifies that dietary intake is actually producing systemic exposure	Requires a 24-hour collection and a research mass-spectrometry assay, not offered by consumer laboratories; useful only where conversion failure is suspected

Qualitative markers worth tracking alongside the laboratory panel:

Upper gastrointestinal comfort, specifically burning, reflux or nausea following cruciferous-heavy meals
Bloating and flatulence, which rise with cruciferous fiber independently of iberin and are the commonest reason protocols are abandoned
Cold intolerance, unexplained fatigue or dry skin, the earliest subjective signs of falling thyroid output
Energy levels and cognitive clarity through the day, as the non-specific markers most often reported to change
Sleep quality, tracked to confirm the absence of the interaction that mechanism predicts should not occur

Emerging Research

Cruciferous metabolite signatures: NCT04641026, an Oregon State University study of 83 healthy adults, profiles plasma and urinary isothiocyanate metabolites plus gut microbiome composition after a single cruciferous serving - the design that could finally separate iberin exposure from sulforaphane exposure in people.
Broccoli seed and sprout extract in heavy smokers: NCT05121051, a National Cancer Institute phase 2 trial in 135 participants, measures detoxification of benzene and acrolein. Its extract carries glucoiberin alongside glucoraphanin, so any effect is partly attributable to iberin.
Broccoli extract bioavailability: NCT07564674, an Oregon State University study recruiting 12 participants, compares supplement formats on plasma and urinary isothiocyanate recovery - directly relevant to whether any commercial format delivers meaningful iberin.
Timing of intake and exercise performance: NCT07461194, a 30-participant Swedish School of Sport and Health Sciences study with lactate, glucose and glycogen endpoints, will test whether cruciferous isothiocyanates help or hinder training, addressing the blunting concern.
Microbiome control of conversion: Bouranis et al., 2021 showed that some gut communities divert glucoiberin to inert iberin-nitrile. If confirmed, this would explain heterogeneous responses and could weaken the case for population-level cruciferous recommendations.
Synthetic iberin analogues: Prieto et al., 2025 built carbohydrate-based iberin derivatives that are stable solids rather than corrosive liquids, with comparable Nrf2 activation, opening a route to a dosable compound that the natural molecule cannot support.
Evidence that could weaken the case: Elbarbry et al., 2024 found iberin was not among the potent inhibitors of soluble epoxide hydrolase (an enzyme whose inhibition relaxes blood vessels), where sulforaphane led, and the earliest rat feeding study (Staack et al., 1998) credited almost all detoxification-enzyme induction to other Brussels sprouts constituents.

Conclusion

Iberin is one of the reactive sulfur compounds released when cabbage-family vegetables are cut or chewed. It is a close relative of sulforaphane, differing by a single carbon, and works the same way: by reacting with sensor proteins that switch on the cell’s own protective, waste-clearing and inflammation-damping programs.

What is known about it comes almost entirely from cells in culture and a handful of animal experiments. In those settings it turns on protective genes about as strongly as sulforaphane, quiets inflammatory signaling, halts and kills a range of cultured tumor cells, disarms the signaling bacteria use to organize themselves into protective layers, and limits kidney damage in rats. None of that has been tested against a health outcome in a person. The only human measurements show how much reaches the blood and urine after a vegetable meal, which confirms exposure and says nothing about benefit. The animal record is not uniformly positive either, and both the earliest and the most recent comparisons place iberin at the weaker end of its chemical family.

The safety picture is correspondingly thin, resting on short studies of related compounds from the same vegetables, including thyroid measurements that did not move. Almost all of this work is academic rather than commercially funded, though the one consumer-facing source cited here is published by a company selling the extracts it describes. For anyone tracking early longevity compounds, iberin sits at the laboratory end: interesting for how it works, untested in people.

Top - Benefits - Risks - Protocol

Iberin for Health & Longevity

Motivation

Recommended Reading

Grokipedia

Examine

ConsumerLab

Systematic Reviews

Mechanism of Action

Historical Context & Evolution

Expected Benefits

High 🟩 🟩 🟩

Medium 🟩 🟩

Low 🟩

Reliable Systemic Exposure from Ordinary Cruciferous Meals

Speculative 🟨

Activation of the Nrf2 Antioxidant and Detoxification Program ⚠️ Conflicted

Suppression of Inflammatory Signaling

Growth Arrest and Apoptosis in Tumor Cell Lines

Quorum-Sensing Inhibition and Antibacterial Activity

Protection Against Kidney Ischemia-Reperfusion Injury

Benefit-Modifying Factors

Potential Risks & Side Effects

High 🟥 🟥 🟥

Medium 🟥 🟥

Low 🟥

Gastrointestinal and Oropharyngeal Irritation

Thyroid Function Disruption ⚠️ Conflicted

Speculative 🟨

Cytotoxicity and Oxidative Stress in Non-Malignant Cells

DNA Damage Response and Necrosis Above the Cytotoxic Threshold

Altered Handling of Co-Administered Medications

Mucosal and Airway Irritation from Concentrated Preparations

Risk-Modifying Factors

Key Interactions & Contraindications

Risk Mitigation Strategies

Therapeutic Protocol

Discontinuation & Cycling

Sourcing and Quality

Practical Considerations

Interaction with Foundational Habits

Monitoring Protocol & Defining Success

Emerging Research

Conclusion